We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of Debio 0932

News   Feb 21, 2012

 
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of Debio 0932
 
 
Advertisement
 

RELATED ARTICLES

How SARS-CoV-2 Could Be Prevented From Invading a Host Cell

News

Researchers have suggested that the inhibition of two key proteases on the surface of host cells could prevent SARS-CoV-2 from being able to invade.

READ MORE

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News

UK charity LifeArc has awarded Vicore Pharma approximately £1.5 million for the ATTRACT VP01 (C21) COVID-19 study.

READ MORE

Study Explores How Ketamine Works Against Depression

News

The anesthetic drug ketamine administered in low doses, has been shown to help treat difficult-to-treat depression. A research team has now identified a key target for the drug – specific serotonin receptors in the brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE